IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.
Clin Immunol
; 174: 63-72, 2017 01.
Article
em En
| MEDLINE
| ID: mdl-27876460
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Psoríase
/
Receptor Toll-Like 9
/
Receptor 7 Toll-Like
/
Receptor 8 Toll-Like
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article